
Lexicon Pharmaceuticals, Inc. Share Price
NASDAQ: LXRXHealthcare
Live Lexicon Pharmaceuticals, Inc. Share Price Chart
O H L
Lexicon Pharmaceuticals, Inc. Performance Overview
Days Range
▼
$2.00Low
$2.02High
Markets Today
| Previous Close | $2.04 |
|---|---|
| Open | $2.02 |
| Volume | 312,834 |
| Day's Range | $2.00 - $2.02 |
| 52W Range | $1.06 - $2.68 |
| Market Cap | $898.81 M |
Historical Performance
| 1M Returns | -15.91 |
|---|---|
| 3M Returns | +1.24 |
| 6M Returns | +30.45 |
| 1Y Returns | +66.80 |
| 5Y Returns | -58.13 |
| 10Y Returns | -89.24 |
Lexicon Pharmaceuticals, Inc. Fundamentals
| Market Cap | $898.81 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $49.65 M |
| ROE TTM | -0.40 |
| EPS TTM | $-0.15 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.15 |
| EBITDA | $-48.45 M |
| Profit Margin | -101.40 |
| Market Cap | $898.81 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $49.65 M |
| ROE TTM | -0.40 |
| EPS TTM | $-0.15 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.15 |
| EBITDA | $-48.45 M |
| Profit Margin | -101.40 |
Lexicon Pharmaceuticals, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $1.26 M | $28.87 M | $14.18 M | $5.34 M | $21.10 M | $692.00 K |
| Gross Profit + | $1.23 M | $28.83 M | $14.17 M | $5.14 M | $20.99 M | $653.00 K |
| Operating Income | -$27.51 M | $3.74 M | -$12.19 M | -$14.94 M | -$2.59 M | -$26.54 M |
| EBITDA | -$27.34 M | $3.91 M | -$12.04 M | -$14.82 M | -$2.48 M | -$26.44 M |
| Interest Expense | $0 | -$2.32 M | -$2.15 M | -$2.03 M | $0 | -$2.61 M |
| Depreciation | $176.00 K | $176.00 K | $151.00 K | $118.00 K | $110.00 K | $102.00 K |
| Income Before Tax | -$25.30 M | $3.25 M | -$12.77 M | -$15.53 M | -$1.04 M | -$31.77 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$25.30 M | $3.25 M | -$12.77 M | -$15.53 M | -$1.04 M | -$31.77 M |
| Net Profit Margin | -2004.36% | 11.27% | -90.04% | -290.99% | -4.94% | -4591.76% |
Lexicon Pharmaceuticals, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $366.00 K | $366.00 K | $366.00 K | $366.00 K | $426.00 K | $447.00 K |
| Reserve & Surplus | -$1.99 B | -$1.99 B | -$2.00 B | -$2.02 B | -$2.02 B | -$2.05 B |
| Non-Current Liabilities | $63.95 M | $61.31 M | $64.05 M | $56.58 M | $56.06 M | $60.83 M |
| Current Liabilities | $110.69 M | $34.84 M | $21.72 M | $20.87 M | $9.90 M | $14.71 M |
| Total Liabilities | $174.64 M | $96.14 M | $85.77 M | $77.45 M | $65.96 M | $75.53 M |
| Fixed Assets | $2.31 M | $2.13 M | $1.98 M | $1.86 M | $1.75 M | $1.65 M |
| Current Assets | $245.81 M | $145.08 M | $122.53 M | $101.89 M | $186.03 M | $196.58 M |
| Total Assets | $297.67 M | $225.58 M | $205.93 M | $184.99 M | $268.82 M | $250.06 M |
Lexicon Pharmaceuticals, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$25.30 M | $3.25 M | -$12.77 M | -$15.53 M | -$1.04 M | -$31.77 M |
| Operating Cash Flow | -$43.78 M | $16.99 M | -$23.83 M | -$17.23 M | -$14.73 M | -$9.19 M |
| Investing Cash Flow | $40.58 M | $15.48 M | $52.13 M | $4.83 M | -$70.26 M | -$16.46 M |
| Financing Cash Flow | -$572.00 K | -$45.00 M | $0 | -$2.93 M | $88.76 M | -$512.00 K |
| Change in Cash | -$3.77 M | -$12.52 M | $28.29 M | -$15.33 M | $3.76 M | -$26.16 M |
Lexicon Pharmaceuticals, Inc. Return Calculator
The Lexicon Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$4,136
Invested Amount$10,000
Est. Returns$-5,864
About Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Popular Stocks
FAQs
What is the share price of Lexicon Pharmaceuticals, Inc. today?
Lexicon Pharmaceuticals, Inc. (LXRX) share price as of September 18, 2026 is $2.01. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Lexicon Pharmaceuticals, Inc.?
Yes, Indian Investors can invest in the Lexicon Pharmaceuticals, Inc. (LXRX) Share by opening an international trading account with Angel One.
How can I purchase Lexicon Pharmaceuticals, Inc. shares in India?
Purchasing Lexicon Pharmaceuticals, Inc. (LXRX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Lexicon Pharmaceuticals, Inc. (LXRX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Lexicon Pharmaceuticals, Inc.?
Yes, you can purchase fractional shares of Lexicon Pharmaceuticals, Inc. (LXRX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Lexicon Pharmaceuticals, Inc.?
The market capitalization of Lexicon Pharmaceuticals, Inc. on September 18, 2026, is $898.81 M.
In which sector Lexicon Pharmaceuticals, Inc. belongs?
Lexicon Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Lexicon Pharmaceuticals, Inc. stocks?
In order to invest in Lexicon Pharmaceuticals, Inc. (LXRX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
